• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Mitomycin-C after surface ablation can prevent corneal haze


Anaheim, CA-Mitomycin-C (MMC), a potent radiomimetic compound, is a useful treatment to prevent corneal haze after surface ablation in patients undergoing PRK who have greater than -7 D of myopia or an ablation depth greater than 75 ?m. It is also a good option for patients who develop late-onset haze after refractive surgery and those who have complications such as buttonholes or partial flaps after attempted LASIK, according to Randy J. Epstein, MD, who spoke during the International Society of Refractive Surgery/American Academy of Ophthalmology refractive surgery subspecialty day meeting.

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
Katherine Talcott, MD, presenting slides
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.